A61K 2039/55583
Polysaccharides
Official title: {Polysaccharides}
A61K2039/55583 (Polysaccharides) appears on 432 US grants and 648 published applications in this corpus.
Search patents in A61K- Granted patents
- 432
- Published applications
- 648
- Assignees
- 383
- Inventors
- 1,312
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 0 | 0 |
| 1982 | 4 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 4 | 0 |
| 1996 | 3 | 0 |
| 1997 | 5 | 0 |
| 1998 | 12 | 0 |
| 1999 | 16 | 0 |
| 2000 | 4 | 0 |
| 2001 | 6 | 1 |
| 2002 | 8 | 2 |
| 2003 | 4 | 11 |
| 2004 | 1 | 16 |
| 2005 | 0 | 15 |
| 2006 | 2 | 14 |
| 2007 | 1 | 7 |
| 2008 | 6 | 16 |
| 2009 | 10 | 20 |
| 2010 | 12 | 21 |
| 2011 | 10 | 32 |
| 2012 | 6 | 24 |
| 2013 | 10 | 26 |
| 2014 | 15 | 25 |
| 2015 | 20 | 29 |
| 2016 | 26 | 38 |
| 2017 | 27 | 45 |
| 2018 | 24 | 30 |
| 2019 | 24 | 35 |
| 2020 | 27 | 44 |
| 2021 | 26 | 42 |
| 2022 | 25 | 40 |
| 2023 | 24 | 33 |
| 2024 | 15 | 37 |
| 2025 | 16 | 26 |
| 2026 | 10 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of membrane inhibitors to enhance vaccine development against enveloped viruses8 Sep 2026US 12,728,161 B2Cornell University
- Modified gene vaccines against avian coronaviruses and methods of using the same21 Jul 2026US 12,685,766 B2Wisconsin Alumni Research Foundation
- Varicella zoster7 Jul 2026US 12,673,101 B2Adjuvance Technologies, Inc.
- Compositions and methods for metal containing formulations capable of modulating immune response12 May 2026US 12,622,922 B2The Regents of the University of Michigan
- Anti-Müllerian hormone receptor 2 antibodies and methods of use5 May 2026US 12,617,858 B2The Cleveland Clinic Foundation
- Development of carbohydrate-based anti-salmonella vaccines8 Oct 2026US 2026/0306602 A1Board of Trustees of Michigan State University
- A broadly protective prophylactic vaccine against pseudomonas aeruginosa24 Sep 2026US 2026/0284172 A1University of Kansas
- Polysaccharide adjuvants for use in protein-based or rna-based vaccines24 Sep 2026US 2026/0284187 A1Children's Medical Center Corporation
- Respiratory dry powder delivery13 Aug 2026US 2026/0232581 A1Board of Regents, The University of Texas System
- Adjuvant formulation including low viscosity chitosan or chitosan derivatives13 Aug 2026US 2026/0232790 A1Merck Sharp & Dohme Corp.
Most cited
By later US patents
- Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site1,449US 7,718,180 B22010
- Glucan drug delivery system and adjuvant141US 5,607,677 AAlpha-Beta Technology, Inc. · 1997
- Glucan drug delivery system and adjuvant126US 5,032,401 AAlpha-Beta Technology, Inc. · 1991
- Immunostimulatory microsphere125US 5,008,116 A1991
- Vaccines102US 6,544,518 B1SmithKline Beecham Biologicals s.a. · 2003